Loading...

Tecan Group AG

TECN.SW•SIX
Healthcare
Medical - Instruments & Supplies
CHF164.80
CHF-2.40(-1.44%)

Tecan Group AG (TECN.SW) Stock Overview

Explore Tecan Group AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap2.1B
P/E Ratio31.07
EPS (TTM)$5.29
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Week$153.36
1 Month$145.28
3 Months$125.88
1 Year Target$236.33

TECN.SW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Tecan Group AG (TECN.SW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.89, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $236.33.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 31.07 and a market capitalization of 2.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Technical Indicators

52.89RSI (14)
-0.05MACD
12.36ADX
Stats data is not available for TECN.SWStats details for TECN.SW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for TECN.SWAnalyst Recommendations details for TECN.SW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Tecan Group AG provides laboratory instruments and solutions for pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and microbodies, and software; Tecan Laberwax, an automation solution; Resolvex, a smart sample preparation solution for use in genomics, synthetic biology, drug discovery, analytical chemistry, cell biology, protein science, applied markets, and ELISA solutions. It also develops and manufactures laboratory instrument manufacturers with essential components comprising precision pumps, valves, robotic arms, and developer software for life science research, diagnostics, and various other industries; Synergence, platform-based automation solution; and Freedom EVO and Fluent instruments. The company operates in Switzerland and Other European countries, North America, Asia, and internationally. Tecan Group AG was founded in 1980 and is headquartered in Männedorf, Switzerland.

CEO

Achim von Leoprechting

Employees

3,074

Headquarters

Seestrasse 103, Männedorf

Founded

1995

Frequently Asked Questions

;